Opportunity ID: 306280

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-18-830
Funding Opportunity Title: The Role of Epitranscriptomics in Development and Disease (R01 – Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 14, 2018
Last Updated Date:
Original Closing Date for Applications: Jun 03, 2021
Current Closing Date for Applications: Jun 03, 2021
Archive Date: Jul 09, 2021
Estimated Total Program Funding:
Award Ceiling: $499,999
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Public housing authorities/Indian housing authorities
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Public and State controlled institutions of higher education
County governments
Independent school districts
State governments
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known. The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), and the National Eye Institute (NEI).
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-18-830.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00243088 Oct 07, 2018 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259265 Oct 07, 2018 Jun 03, 2021 View

Package 1

Mandatory forms

306280 RR_SF424_2_0-2.0.pdf

306280 PHS398_CoverPageSupplement_4_0-4.0.pdf

306280 RR_OtherProjectInfo_1_4-1.4.pdf

306280 PerformanceSite_2_0-2.0.pdf

306280 RR_KeyPersonExpanded_2_0-2.0.pdf

306280 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

306280 RR_Budget_1_4-1.4.pdf

306280 RR_SubawardBudget30_1_4-1.4.pdf

306280 PHS398_ModularBudget_1_2-1.2.pdf

306280 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

306280 RR_SF424_2_0-2.0.pdf

306280 PHS398_CoverPageSupplement_5_0-5.0.pdf

306280 RR_OtherProjectInfo_1_4-1.4.pdf

306280 PerformanceSite_2_0-2.0.pdf

306280 RR_KeyPersonExpanded_2_0-2.0.pdf

306280 PHS398_ResearchPlan_4_0-4.0.pdf

306280 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

306280 RR_Budget_1_4-1.4.pdf

306280 RR_SubawardBudget30_1_4-1.4.pdf

306280 PHS398_ModularBudget_1_2-1.2.pdf

306280 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T15:42:45-05:00

Share This Post, Choose Your Platform!

About the Author: